Glutamine Effects in Burn Patients

NCT05140772 · Status: UNKNOWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2021-12-01

No results posted yet for this study

Summary

The study is designed to evaluate the effect of parenteral glutamine supplementation on infection in burn patients.

Conditions

  • Drug Effect

Interventions

DRUG

Dipeptiven

IV administration daily for 7 days

DRUG

normal Saline

IV administration daily for 7 days

Sponsors & Collaborators

  • Menoufia University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-01
Primary Completion
2021-12-01
Completion
2021-12-01

Countries

  • Egypt

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05140772 on ClinicalTrials.gov